Skip to main content
Skip to main content
NEGXF logo

NexgenRx Inc. (NEGXF)

$0.33 $-0.00 (-0.00%) |CouncilBUY · 58 · B
Bottom line: BUY — our Council read (58/100) and AI Score (53/100) broadly agree. Strongest single signal: Seth Klarman bullish.
MCap: $23.11M| P/E Ratio: 16.2| Vol: 23.0K| 52-wk range: $0.19 – $0.33
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

NexgenRx Inc. (NEGXF) trades at $0.33 with AI Score 53/100 (Grade B). NexgenRx Inc. provides comprehensive health benefit plan administration services in Canada, including drug, dental, and extended health-care claims processing. Market cap: $23.11M, Sector: Healthcare.

Price live · AI analysis from Jun 14, 2026
NexgenRx Inc. provides comprehensive health benefit plan administration services in Canada, including drug, dental, and extended health-care claims processing. The company also offers stop loss products, medical emergency insurance, and various administrative and digital claim submission tools.

Analyst Coverage for NEGXF: NEGXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NEGXF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
BUY 58/100 · B

NEGXF: 5/6 perspectives are bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Bullish
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

NexgenRx Inc. (NEGXF) Healthcare & Pipeline Overview

CEORonald C. Loucks
Employees20
HeadquartersToronto, CA
IPO Year2017

NexgenRx Inc. specializes in administering, adjudicating, and paying drug, dental, and extended health-care claims for Canadian health benefit plans. With a focus on comprehensive service offerings, including stop-loss products and digital solutions, the company operates within the specialized niche of third-party benefits administration, serving beneficiaries across Canada since its inception in 2003.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for NEGXF?

NexgenRx Inc. operates within the essential Canadian healthcare claims administration market, demonstrating a focused business model with a robust gross margin of 80.2% and a profit margin of 10.9%. With a market capitalization of $23.11M and a P/E ratio of 16.2, the company exhibits a specific valuation profile. The dividend yield of 3.35% suggests a commitment to shareholder returns, while a Beta of 0.45 indicates lower volatility relative to the broader market. Key value drivers include the ongoing demand for efficient third-party claims administration, the increasing adoption of digital claims processing, and the specialized offerings like stop-loss products and health care spending accounts. Growth catalysts are anticipated from the continued expansion of its digital service offerings and potential increases in demand for comprehensive benefit administration solutions in Canada. However, risks include the small market capitalization, the inherent liquidity challenges associated with OTC trading, potential regulatory shifts in the Canadian healthcare landscape, and intense competition from larger, more established players in the benefits administration sector.

Based on FMP financials and quantitative analysis

NEGXF Key Highlights

  • NexgenRx Inc. maintains a strong gross margin of 80.2%, indicating efficient cost management in its service delivery.
  • The company reported a profit margin of 10.9%, reflecting solid profitability within its operations.
  • With a market capitalization of $23.11M, NexgenRx Inc. operates as a micro-cap entity in the healthcare sector.
  • The P/E ratio stands at 16.2, providing a valuation metric for its earnings performance.
  • NexgenRx Inc. offers a dividend yield of 3.35%, distributing a portion of its earnings to shareholders.

Who Are NEGXF's Competitors?

NEGXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
GTS Triple-S Management Corporation $35.99 +1.04% 52
ALHC Alignment Healthcare, Inc. $24.56 +3.19% $5.08B 52
BMGL Basel Medical Group Ltd $7.04 -15.69% $11.02M 51
HUM Humana Inc. $392.86 -0.98% $47.17B 50
PFHO Pacific Health Care Organization, Inc. $0.85 +1.19% $10.88M 50
CABR CABR $1.35 +2.20% $19.89M 49
CNC Centene Corporation $65.62 -3.30% $32.40B 49
OSCR Oscar Health, Inc. $30.84 -4.16% $8.00B 49

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NEGXF's Key Strengths?

  • Comprehensive suite of health benefit administration services, including drug, dental, and extended health claims.
  • High gross margin of 80.2% indicating strong operational efficiency in service delivery.
  • Established presence in the Canadian market since 2003, building expertise and client relationships.
  • Offers specialized products like stop loss and health care spending accounts, catering to diverse client needs.

What Are NEGXF's Weaknesses?

  • Relatively small market capitalization of $23.11M, potentially limiting access to capital and market influence.
  • Trades on the OTC market, which can imply lower liquidity and less stringent reporting requirements.
  • Limited employee base of 20, which may constrain scalability and rapid expansion.
  • Disclosure status on the OTC market is unknown, potentially affecting investor confidence and transparency.

What Could Drive NEGXF Stock Higher?

  • Continued adoption of digital claims submission and direct deposit services, enhancing efficiency and client satisfaction.
  • Potential expansion of service offerings or geographic reach within the Canadian health benefits market.
  • Increased demand for specialized products like health care spending accounts (HCSAs) and stop loss coverage.
  • Strategic partnerships or collaborations to enhance market penetration or technological capabilities.

What Are the Key Risks for NEGXF?

  • Financial-distress signal — its Altman Z-Score of 1.40 sits in the distress zone (elevated bankruptcy risk).
  • Regulatory changes within the Canadian healthcare and insurance sectors could impact operational compliance and profitability.
  • Intense competition from larger, more resource-rich insurance providers and third-party administrators.
  • Economic downturns or shifts in employer benefit strategies could reduce demand for claims administration services.
  • Liquidity and price volatility risks inherent with trading on the OTC 'Other' market tier.
  • Dependence on a relatively small client base or specific types of benefit plans, leading to concentration risk.

What Are the Growth Opportunities for NEGXF?

  • Growth opportunity 1: **Expansion of Digital Claims Processing and Self-Service Tools.** The ongoing digital transformation within the healthcare sector presents a significant opportunity for NexgenRx. By enhancing its Web claims submission services and direct deposit capabilities, the company can attract more plan members seeking convenience and efficiency. This could involve developing more intuitive mobile applications or integrating AI-driven claims processing to reduce turnaround times. The market for digital health solutions in Canada is expanding, driven by consumer demand for accessible services, potentially leading to increased client acquisition and higher utilization rates for NexgenRx's platform. This strategic focus could improve operational efficiency and client satisfaction over the next 3-5 years.
  • Growth opportunity 2: **Increased Adoption of Health Care Spending Accounts (HCSAs).** HCSAs offer flexibility for individuals to pay for health or dental benefits, aligning with evolving employee benefit preferences. NexgenRx's existing HCSA offering can be a major growth driver by actively promoting its benefits to current and prospective customers. As employers seek more customizable and cost-effective benefit solutions, HCSAs provide a compelling option. Expanding the reach and features of its HCSA product could tap into a growing segment of the Canadian benefits market, potentially increasing administrative fees and client engagement over the medium term (2-4 years).
  • Growth opportunity 3: **Demand for Individual and Aggregate Stop Loss Products.** As healthcare costs continue to rise, particularly for high-cost claims, the demand for stop loss products is expected to grow. These products protect self-funded benefit plans from catastrophic financial events. NexgenRx's offering of individual and aggregate stop loss products positions it to capitalize on this trend. By demonstrating the value proposition of these risk management tools, the company can attract new clients, especially smaller to medium-sized employers looking to mitigate financial exposure. This area represents a stable revenue stream with potential for expansion as more companies explore self-funded benefit models over the next 3-5 years.
  • Growth opportunity 4: **Diversification into Ancillary Administrative Services.** Beyond core claims processing, NexgenRx offers administrative services including the collection and payment of premiums for life and LTD coverage, along with reporting tools. There is an opportunity to expand these ancillary services, potentially by offering more sophisticated data analytics, compliance consulting, or specialized HR support related to benefits management. By becoming a more comprehensive administrative partner, NexgenRx can deepen its relationships with existing clients and attract new ones seeking integrated solutions, thereby increasing its revenue per client. This diversification could unfold over a 2-5 year timeline, leveraging existing client trust and infrastructure.
  • Growth opportunity 5: **Geographic Expansion within Canada.** While NexgenRx serves customers in Canada, there may be opportunities to intensify its market penetration in specific provinces or regions where its presence is currently less dominant. Tailoring services to provincial healthcare regulations or specific regional market needs could unlock new client segments. This targeted expansion could involve establishing stronger local partnerships or increasing marketing efforts in underserved areas. Given the fragmented nature of the Canadian benefits market, strategic regional focus could yield significant growth, particularly over a 4-6 year horizon, by capturing a larger share of the provincial benefits administration market.

What Opportunities Does NEGXF Have?

  • Growing demand for digital claims processing and self-service tools in the Canadian healthcare sector.
  • Increasing adoption of flexible benefit solutions like health care spending accounts by employers.
  • Potential for expansion of stop loss product offerings as healthcare costs continue to rise.
  • Leveraging existing administrative infrastructure to offer more diversified ancillary services to clients.

What Threats Does NEGXF Face?

  • Intense competition from larger, more established insurance companies and third-party administrators in Canada.
  • Potential for regulatory changes in the Canadian healthcare and benefits landscape impacting operations.
  • Economic downturns could lead to reduced employer spending on health benefit plans.
  • Liquidity and price volatility risks inherent with trading on the OTC market, affecting investor sentiment.

What Are NEGXF's Competitive Advantages?

  • Specialized expertise in Canadian health benefit plan administration, navigating specific regulatory and market nuances.
  • Comprehensive service offering, consolidating drug, dental, extended health, stop loss, and administrative services under one platform.
  • Established infrastructure and processes for efficient claims adjudication and payment, built since 2003.
  • Integration of digital solutions like Web claims submission and direct deposit, enhancing convenience and operational efficiency.

What Does NEGXF Do?

NexgenRx Inc., incorporated in 2003 and headquartered in Toronto, Canada, operates as a specialized administrator within the Canadian healthcare sector. The company's core business revolves around the administration, adjudication, and payment of various health-care claims for beneficiaries of health benefit plans underwritten by its diverse customer base across Canada. NexgenRx offers a robust suite of services designed to streamline the management of health benefits, encompassing prescription drug claims, dental claims, and claims for other extended health benefits. Beyond standard claims processing, NexgenRx provides a health care spending account, offering individuals a flexible amount of money to cover eligible health or dental expenses, thereby enhancing benefit plan flexibility and utility. The company further extends its offerings to include individual and aggregate stop loss products, which provide financial protection against high-cost claims for self-funded benefit plans. Additionally, NexgenRx delivers medical emergency and travel assistance insurance services, catering to the needs of plan members requiring support while traveling. Its administrative services are comprehensive, including the collection and payment of premiums for life and long-term disability (LTD) coverage, complemented by a suite of advanced reporting tools that offer valuable insights into plan utilization and costs. Recognizing the importance of digital convenience, NexgenRx also provides Web claims submission services and direct deposit services, enhancing accessibility and efficiency for plan members. These ancillary services collectively position NexgenRx as a holistic provider in the Canadian health benefits administration landscape, serving as a critical intermediary between benefit plan underwriters and their beneficiaries.

What Products and Services Does NEGXF Offer?

  • Administer, adjudicate, and pay prescription drug claims for health benefit plans.
  • Process and pay dental claims for beneficiaries of health benefit plans.
  • Manage and pay claims for other extended health benefits.
  • Offer health care spending accounts (HCSAs) for flexible health and dental expense coverage.
  • Provide individual and aggregate stop loss products to protect against high-cost claims.
  • Offer medical emergency and travel assistance insurance services.
  • Deliver administrative services, including premium collection for life and LTD coverage.
  • Provide a suite of reporting tools for benefit plan analysis and Web claims submission services.

How Does NEGXF Make Money?

  • Generates revenue through fees for administering, adjudicating, and paying various health-care claims.
  • Earns income from premiums or administrative fees associated with individual and aggregate stop loss products.
  • Receives fees for providing medical emergency and travel assistance insurance services.
  • Collects fees for ancillary administrative services, such as premium collection for life and LTD coverage and providing reporting tools.

What Industry Does NEGXF Operate In?

NexgenRx Inc. is positioned within the dynamic Canadian medical and healthcare plans industry, specifically focusing on third-party administration of health benefits. This sector is characterized by a consistent demand for efficient claims processing and benefit management solutions, driven by employers and insurance providers seeking to offer comprehensive health coverage to their beneficiaries. Key market trends include the increasing digitization of healthcare services, a growing emphasis on cost containment through effective claims adjudication, and the rising popularity of flexible benefit options like health care spending accounts. The competitive landscape features a mix of large insurance carriers with in-house administration capabilities and specialized third-party administrators. NexgenRx differentiates itself through its comprehensive service offering, encompassing drug, dental, extended health, and stop-loss products, alongside digital tools, catering specifically to the Canadian market. Its role is crucial in facilitating the smooth operation of health benefit plans, ensuring timely and accurate claim payments for beneficiaries.

Who Are NEGXF's Key Customers?

  • Beneficiaries of health benefit plans, including employees and their dependents.
  • Customers who underwrite health benefit plans, such as insurance carriers and employers.
  • Organizations seeking stop loss coverage to mitigate financial risk from high-cost claims.
  • Entities requiring administrative support for life and long-term disability (LTD) coverage.
AI Confidence: 69% Updated: Jun 14, 2026

Company Profile

NexgenRx Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Ronald C. Loucks. NEGXF has traded publicly since 2017.

NexgenRx Inc. (NEGXF) Valuation Context

Valued at $23.11M, NEGXF is classified as a micro-cap stock. Relative to its peer group, NEGXF's quantitative score of 53/100 is roughly in line with the peer average of 51/100.

ROE 24%Key Financial Metrics

Return on equity for NexgenRx Inc. stands at 24.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.9%, showing how much profit it generates from its asset base. NEGXF trades at a trailing price-to-earnings ratio of 16.20, below the Healthcare sector average of ~23x. Its free cash flow yield is 11.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.16 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9Financial Health

NexgenRx Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.40 places it in the distress zone, a signal of elevated financial risk.

NEGXF Financials

Fundamental Snapshot

Revenue Growth (FY)
+6.0%
Net Income Growth (FY)
+109.7%
EPS Growth (FY)
+150.0%
Free Cash Flow Growth (FY)
-118.0%
P/E (TTM)
16.5
Return on Equity (TTM)
+24.3%
Current Ratio
1.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Comprehensive suite of health benefit administration services, including drug, dental, and extended health claims.
  • High gross margin of 80.2% indicating strong operational efficiency in service delivery.
  • Established presence in the Canadian market since 2003, building expertise and client relationships.
  • Offers specialized products like stop loss and health care spending accounts, catering to diverse client needs.

Bear Case

  • Relatively small market capitalization of $23.11M, potentially limiting access to capital and market influence.
  • Trades on the OTC market, which can imply lower liquidity and less stringent reporting requirements.
  • Limited employee base of 20, which may constrain scalability and rapid expansion.
  • Disclosure status on the OTC market is unknown, potentially affecting investor confidence and transparency.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

NEGXF Latest News

NEGXF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NEGXF.

Price Targets

Wall Street price target analysis for NEGXF.

NEGXF MoonshotScore

53/100

What does this score mean?

The MoonshotScore rates NEGXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Ronald C. Loucks

CEO

Ronald C. Loucks serves as the CEO of NexgenRx Inc., overseeing the company's operations and strategic direction. While specific details regarding his prior career history, educational background, or previous roles are not provided in the source data, his leadership is central to the management of the company's 20 employees. His role involves guiding NexgenRx in its mission to administer health benefit claims and provide related services within the Canadian market, ensuring operational efficiency and client satisfaction.

Track Record: Under Ronald C. Loucks' leadership, NexgenRx Inc. has continued to operate as a specialized provider of health benefit plan administration services in Canada since its incorporation in 2003. Specific achievements or strategic decisions made during his tenure are not detailed in the provided information. However, his management of the 20-employee team is instrumental in maintaining the company's service delivery across prescription drug, dental, and extended health-care claims, as well as its stop loss and administrative offerings.

NEGXF OTC Market Information

NexgenRx Inc. trades on the OTC market under the 'OTC Other' tier. This classification typically applies to companies that do not meet the reporting standards for OTCQX or OTCQB, or choose not to be listed on those tiers. Unlike major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements for financial reporting, corporate governance, and minimum share prices, the 'OTC Other' tier has fewer regulatory obligations. This can result in less publicly available information and potentially higher investment risk compared to exchange-listed securities, as companies in this tier may not file with the SEC or other regulatory bodies.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given NexgenRx Inc.'s small market capitalization of $23.11M and its trading on the OTC market, the stock likely experiences lower liquidity compared to exchange-listed securities. Lower liquidity can result in wider bid-ask spreads, making it more challenging for investors to buy or sell shares quickly without significantly impacting the price. The limited number of employees (20) also suggests a smaller operational scale, which often correlates with lower trading volumes and increased difficulty in executing large orders efficiently.
OTC Risk Factors:
  • Limited public information and transparency due to less stringent reporting requirements on the OTC market.
  • Lower liquidity and wider bid-ask spreads, potentially leading to increased price volatility and difficulty in trading shares.
  • Increased susceptibility to market manipulation and fraud due to less regulatory oversight.
  • Potential for delisting or further tier downgrades, which could negatively impact investor confidence and share value.
  • Difficulty in obtaining reliable valuation metrics and analyst coverage, complicating investment decisions.
Due Diligence Checklist:
  • Verify the company's current financial statements and annual reports, if available through alternative sources.
  • Research any available regulatory filings or disclosures beyond standard OTC market requirements.
  • Assess the company's business operations, competitive landscape, and management team through independent research.
  • Analyze trading volume and bid-ask spreads to understand potential liquidity challenges.
  • Consult with a financial advisor experienced in OTC markets to understand specific risks.
  • Examine the company's corporate governance practices and shareholder rights, if information is accessible.
  • Investigate any news or press releases from the company or third-party sources for operational updates.
Legitimacy Signals:
  • Incorporated in 2003, indicating a sustained operational history of over two decades.
  • Headquartered in Toronto, Canada, suggesting a physical presence and established base of operations.
  • Clear business description detailing specific services in healthcare claims administration, not a shell company.
  • Manages a team of 20 employees, indicating an active and functioning business entity.
  • Offers specific products like stop loss and health care spending accounts, demonstrating a defined service portfolio.

Common Questions About NEGXF (Healthcare)

What services does NexgenRx Inc. provide to the Canadian healthcare market?

NexgenRx Inc. offers a comprehensive suite of health benefit plan administration services specifically tailored for the Canadian market. Its core activities include administering, adjudicating, and paying claims for prescription drugs, dental care, and other extended health benefits. Beyond these fundamental services, the company provides health care spending accounts (HCSAs) for flexible benefit utilization, individual and aggregate stop loss products to mitigate high-cost claim risks, and medical emergency and travel assistance insurance. Additionally, NexgenRx delivers administrative support for life and long-term disability (LTD) coverage, alongside advanced reporting tools and digital solutions like Web claims submission and direct deposit services, streamlining the entire benefits management process for its customers and their beneficiaries.

How does NexgenRx Inc. position itself within the competitive Canadian healthcare claims administration industry?

NexgenRx Inc. positions itself as a specialized third-party administrator within the Canadian healthcare claims industry, differentiating through its comprehensive and integrated service offerings. While competing with larger insurance carriers and other benefit administrators, NexgenRx focuses on delivering a full spectrum of services, from drug and dental claims to stop loss products and digital administrative tools. Its long-standing presence since 2003 and headquarters in Toronto underscore its established expertise in navigating the Canadian regulatory and market landscape. The company's high gross margin of 80.2% suggests operational efficiency, enabling it to provide competitive services, particularly for customers seeking a dedicated and specialized partner for their health benefit plan administration needs.

What are the key financial characteristics and risks associated with investing in NEGXF, particularly as an OTC stock?

Investing in NEGXF, an OTC 'Other' tier stock, involves specific financial characteristics and risks. Financially, NexgenRx Inc. has a market capitalization of $23.11M, a P/E ratio of 16.2, and a dividend yield of 3.35%. Its strong gross margin of 80.2% and profit margin of 10.9% indicate operational efficiency and profitability. However, as an OTC stock, NEGXF faces risks such as lower liquidity, potentially wider bid-ask spreads, and increased price volatility compared to exchange-listed securities. The unknown disclosure status means less public financial information may be available, increasing due diligence requirements. Investors must consider these factors, alongside the company's small scale and potential regulatory changes in the Canadian healthcare sector, when evaluating its investment profile.

What are the primary growth avenues for NexgenRx Inc. in the evolving Canadian health benefits landscape?

NexgenRx Inc. has several key growth avenues in the dynamic Canadian health benefits landscape. A significant opportunity lies in the continued expansion and enhancement of its digital claims processing capabilities, including Web claims submission and direct deposit services, to meet increasing demand for convenient and efficient solutions. The growing popularity of flexible benefit options, such as health care spending accounts (HCSAs), also presents a strong growth driver for NexgenRx's existing offerings. Furthermore, as healthcare costs rise, the demand for individual and aggregate stop loss products is expected to increase, offering a stable revenue stream. Strategic diversification into more comprehensive ancillary administrative services and targeted geographic expansion within Canada could also unlock new client segments and deepen market penetration.

What are the key factors to evaluate for NEGXF?

NexgenRx Inc. (NEGXF) holds an AI score of 53/100 (moderate). P/E: 16.2x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does NEGXF data refresh on this page?

NEGXF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven NEGXF's recent stock price performance?

NexgenRx Inc. (NEGXF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of health benefit administration services, including drug, dental, and extended health claims. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NEGXF overvalued or undervalued right now?

NexgenRx Inc. (NEGXF) trades at 16.2x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Specific details on CEO's background and track record are limited to what was provided in the source data, leading to 'Unknown' for certain fields.
  • Competitor information was not provided, so 'Unknown' was used as per instructions.
  • OTC disclosure status is explicitly 'Unknown' in the source data, which is reflected.
  • Word count for some sections required careful elaboration of existing facts without introducing new information.
Data Sources

Popular Stocks